Resumption of imatinib to control metastatic or unresectable gastrointestinal stromal tumours after failure of imatinib and sunitinib (RIGHT): a randomised, placebo-controlled, phase 3 trial
Kang, Yoon-Koo, Prof, Ryu, Min-Hee, MD, Yoo, Changhoon, MD, Ryoo, Baek-Yeol, Prof, Kim, Hyun Jin, MD, Lee, Jong Jin, MD, Nam, Byung-Ho, PhD, Ramaiya, Nikhil, MBBS, Jagannathan, Jyothi, MD, Demetri, George D, Prof
Published in The lancet oncology (01.11.2013)
Published in The lancet oncology (01.11.2013)
Get full text
Journal Article